The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.887%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 53.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading & COVID-19 Update

23 Apr 2020 07:00

RNS Number : 5656K
SDI Group PLC
23 April 2020
 

SDI Group plc

 

("SDI", the "Company" or the "Group")

(AIM: SDI)

 

Trading Update

COVID-19 Update

 

SDI Group plc, the AIM quoted Group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing control applications, is pleased to announce an update on trading for the year ending 30 April 2020, and on the impact of COVID-19 on SDI's operations.

 

The Group has a diversified portfolio of companies and since the announcement of a UK "lockdown" on 23 March has continued to operate at all eight of its operating units. The Group continues to expect to meet market profit expectations for the year ending 30 April 2020, with sales of around £24 million.

 

During the period, the Company has taken steps in order to:

- protect the health and wellbeing of our employees;

- reduce business costs as appropriate making use of US and UK Government programmes, whilst still maintaining our capabilities in the short and the long term;

- conserve cash and liquidity;

- support customers in medical and scientific areas that require critical products for the national interest and for the global effort against COVID-19.

 

Employees

We have taken all necessary steps to protect the health of our employees, clients and suppliers. Protocols have been introduced in the workplace and, where possible, staff are now working from home. The Board is extremely proud of the way the Group's employees have reacted to the crisis and is grateful to them and their families.

 

Reducing Costs

Since 23 March, the Group has been actively reducing SDI's overall costs. These include a cut in all SDI board salaries and fees of 33% for a period of three months. The Group has also, where required, furloughed staff with Government support, ensuring the retention of our staff for the future. 19% of SDI staff are currently furloughed and no staff members have been made redundant.

 

Cash and Liquidity

SDI has a strong balance sheet with current cash in excess of £4.5m, unused debt facilities of £0.6m and bank debt of £8.9m. The Group has a good long-term relationship with its bank and has agreed, as a precautionary measure, a capital repayment holiday of three months of its revolving credit facility. The Group has also taken advantage of the UK Government's scheme allowing a temporary VAT payment deferral.

 

Current Trading and Outlook

The Board expects SDI to report profit for the year to 30 April 2020 in line with market expectations.

 

However due to COVID-19 SDI withdraws market guidance for the year to 30 April 2021. There has been some disruption to supply and some slow-down in orders, but SDI currently has all factories in operation and has so far remained both profitable and cash generative. At least four of our production units are providing their customers with components for medical and scientific products used in the fight against COVID-19.

 

Ken Ford, Chairman of SDI, said:

"The Group expects to report profit for the year to 30 April 2020 in line with market expectations. The Group remains open for business, although due to COVID-19, sales are at reduced levels. Demand for some SDI products has increased and the Group looks forward to being able to grow both organically and through acquisition during the new financial year when conditions permit."

 

 

The Group currently expects to announce final results for the year ended 30 April 2020 in July 2020.

 

Enquiries

SDI Group plc 01223 320480

Ken Ford, Chairman

Mike Creedon, CEO

Jon Abell, CFO

www.scientificdigitalimaging.com

 

finnCap Ltd 020 7220 0500

Ed Frisby/Kate Bannatyne - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

JW Communications 07818 430 877

Julia Wilson - Investor & Public Relations

 

About SDI Group plc:

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries and Chell Instruments.

 

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUBPCUPUGMP
Date   Source Headline
22nd Feb 20177:00 amRNSDirectorate Change
7th Feb 20174:29 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSInterim Results
19th Jan 201712:54 pmRNSHolding(s) in Company
12th Jan 20179:35 amRNSHolding(s) in Company
11th Jan 201711:17 amRNSHolding(s) in Company
10th Jan 201712:05 pmRNSResult of General Meeting
20th Dec 20167:00 amRNSEquity Fundraising & Acquisition
23rd Sep 20163:20 pmRNSResult of AGM
22nd Jul 20167:00 amRNSFinal Results
11th Jul 20167:00 amRNSFurther guidance from DoH on contamination levels
24th May 20167:00 amRNSTrading Update
12th Jan 20163:57 pmRNSHolding(s) in Company
8th Jan 20167:00 amRNSHalf Yearly Report
5th Jan 20163:27 pmRNSHolding(s) in Company
17th Nov 20154:58 pmRNSHolding(s) in Company
17th Nov 20152:11 pmRNSHolding(s) in Company
13th Nov 201512:12 pmRNSResult of General Meeting
29th Oct 20151:44 pmRNSDirector Dealing
28th Oct 20155:36 pmRNSAcquisition, Equity Fundraising and Notice of GM
23rd Sep 20152:00 pmRNSResult of AGM
28th Jul 20157:00 amRNSFinal Results
26th May 20157:01 amRNSGuidance from DoH on contamination levels
14th May 20157:00 amRNSTrading Update
9th Feb 20151:00 pmRNSResult of General Meeting
15th Jan 20152:50 pmRNSDirector/PDMR Shareholding
15th Jan 20157:01 amRNSIssue of Equity and Notice of General Meeting
15th Jan 20157:00 amRNSHalf Yearly Report
23rd Sep 201411:54 amRNSResult of AGM
11th Aug 20147:00 amRNSFinal Results for the year ended 30 April 2014
1st Aug 20143:37 pmRNSTotal Voting Rights
20th May 20147:00 amRNSTrading update
1st May 20147:00 amRNSPXi Touch being used at University of Cambridge
10th Apr 20147:00 amRNSHolding(s) in Company
14th Mar 20147:00 amRNSExpansion of Imaging Systems range
14th Feb 20147:00 amRNSAcquisition of Opus Instruments
20th Dec 20137:00 amRNSHalf Yearly Report
14th Oct 20134:30 pmRNSHolding(s) in Company
17th Sep 20137:00 amRNSResult of AGM
29th Aug 20137:00 amRNSNotice of AGM - change of venue
25th Jul 201312:39 pmRNSDirector/PDMR Shareholding
24th Jul 201310:36 amRNSDirector/PDMR Shareholding
24th Jul 20137:01 amRNSRe ProReveal
24th Jul 20137:00 amRNSFinal Results
9th Jul 201311:26 amRNSResult of GM
21st Jun 201311:30 amRNSIssue of Equity, Trading Update and Notice of GM
7th Mar 20133:52 pmRNSCorrection re directors dealings announcements
8th Feb 20137:00 amRNSSale of ProtoCOL 3 Systems to Chinese SFDA
12th Dec 20124:32 pmRNSDirector/PDMR Shareholding
12th Dec 201212:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.